Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro
about
The mechanism of release of P-TEFb and HEXIM1 from the 7SK snRNP by viral and cellular activators includes a conformational change in 7SKIn vitro nuclear interactome of the HIV-1 Tat proteinInhibition of Tat activity by the HEXIM1 proteinHIV-1 gene expression: lessons from provirus and non-integrated DNATat-SF1 protein associates with RAP30 and human SPT5 proteinsFCP1, the RAP74-interacting subunit of a human protein phosphatase that dephosphorylates the carboxyl-terminal domain of RNA polymerase IIOHIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoterEvidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitroStructure and function of the human transcription elongation factor DSIFDistinct regions of MAT1 regulate cdk7 kinase and TFIIH transcription activitiesHEXIM2, a HEXIM1-related protein, regulates positive transcription elongation factor b through association with 7SKHuman transcription elongation factor NELF: identification of novel subunits and reconstitution of the functionally active complexIdentification of HEXIM1 as a positive regulator of p53The functional role of an interleukin 6-inducible CDK9.STAT3 complex in human gamma-fibrinogen gene expressionCyclin K inhibits HIV-1 gene expression and replication by interfering with cyclin-dependent kinase 9 (CDK9)-cyclin T1 interaction in Nef-dependent mannerThe histone chaperone protein Nucleosome Assembly Protein-1 (hNAP-1) binds HIV-1 Tat and promotes viral transcriptionAcetylation of conserved lysines in the catalytic core of cyclin-dependent kinase 9 inhibits kinase activity and regulates transcriptionThe La-related protein LARP7 is a component of the 7SK ribonucleoprotein and affects transcription of cellular and viral polymerase II genesA cofactor, TIP30, specifically enhances HIV-1 Tat-activated transcriptionRequirement for SWI/SNF chromatin-remodeling complex in Tat-mediated activation of the HIV-1 promoterIdentification of multiple cyclin subunits of human P-TEFbAcetylation of cyclin T1 regulates the equilibrium between active and inactive P-TEFb in cellsThe human I-mfa domain-containing protein, HIC, interacts with cyclin T1 and modulates P-TEFb-dependent transcriptionSystematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzymeDSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologsCDK11 complexes promote pre-mRNA splicingPITALRE, the catalytic subunit of TAK, is required for human immunodeficiency virus Tat transactivation in vivo.Analysis of the effect of natural sequence variation in Tat and in cyclin T on the formation and RNA binding properties of Tat-cyclin T complexes.Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stagesDephosphorylation of CDK9 by protein phosphatase 2A and protein phosphatase-1 in Tat-activated HIV-1 transcription.A negative elongation factor for human RNA polymerase II inhibits the anti-arrest transcript-cleavage factor TFIIS.Evidence that negative elongation factor represses transcription elongation through binding to a DRB sensitivity-inducing factor/RNA polymerase II complex and RNA.Spt5 cooperates with human immunodeficiency virus type 1 Tat by preventing premature RNA release at terminator sequencesPhosphorylation of the RNA polymerase II carboxyl-terminal domain by CDK9 is directly responsible for human immunodeficiency virus type 1 Tat-activated transcriptional elongationAcetylation of histones and transcription-related factorsCDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNARelief of two built-In autoinhibitory mechanisms in P-TEFb is required for assembly of a multicomponent transcription elongation complex at the human immunodeficiency virus type 1 promoterDomains in the SPT5 protein that modulate its transcriptional regulatory propertiesThe growth factor granulin interacts with cyclin T1 and modulates P-TEFb-dependent transcriptionhnRNP U inhibits carboxy-terminal domain phosphorylation by TFIIH and represses RNA polymerase II elongation
P2860
Q21136168-F615F19A-D3D2-4A28-825A-B962EDAAAB82Q21245051-6D37381E-EA56-4C19-A838-5A56B35B3623Q21245206-8CC5CB5A-CA28-45C4-BF2D-DFFD3E35B730Q21245215-68D6B30B-EE15-4FF0-95FD-CAF23E82D33DQ22003803-4EA2C0D7-2581-4EF0-8C09-2076EDAB1E4DQ22003918-5B24EDBE-1D8D-4BB0-A7B0-36DC05AA0CE0Q22007982-069BAD8D-4D6B-4BA0-BA48-2F62F30A5FCFQ22008559-7B83C9A7-3544-449C-8393-619914A53867Q22009021-97FB9C0C-8DF3-436E-8EC6-408119004740Q22254055-0C7C4942-DCFC-447A-BF3A-D98F0E74EFB7Q24294998-82AC9D2A-6881-40BC-8BF7-A1894A62898BQ24296462-B012E8D8-3B07-4778-8A30-7C572D93989AQ24297975-258A43EC-1523-48E9-BD37-973E77853358Q24298498-9D928A02-D0DB-4E77-9CDB-F83DF36469BFQ24301811-05F80542-A6E9-4306-B8FB-B3D0EBB395BCQ24307870-F9438841-34A8-4632-BC12-AD4B2888F954Q24310643-F62C3020-5297-4826-B906-F7179E46C92DQ24313106-1B5048EE-5A5F-4863-B2F6-C48404C5DD5FQ24314052-8B7D9BD4-B3A0-4719-8873-17E534C6C735Q24315665-7EE6B70D-3781-4D2C-B311-2FA7DEA04417Q24317025-7B0205EE-E470-4092-997B-26590169F878Q24318644-3C5011B2-19D9-4C06-83AB-1291C8C1EF0CQ24318776-74DF183F-378A-4E7B-AA52-0FAC4B8C228CQ24321455-122792C3-D19E-46EE-9C54-3FB5A904747AQ24328838-8D424DCB-C231-4EF3-ADEC-2759783098DFQ24337666-18A8D979-E5F1-4C91-B358-9402545AA8C9Q24523183-31C23491-53CC-44BD-A629-092B2E9AEE47Q24527261-5CED418C-143C-4217-859F-04825FF1781AQ24533266-19372FFC-1ED0-4DFC-88EC-5489759D7BD5Q24535568-EA2D868D-7146-4244-8C43-2E97606B4CC9Q24536049-C3E336D6-D860-43F9-A3A6-0517FBA0EB0BQ24537283-E12FDD27-55D9-4B14-AA9C-C69407810312Q24537527-DA6AEB7E-7662-4B67-9457-3D004A91FA36Q24537588-03DC4F31-1178-450B-AA78-6D5D6AD7B0BBQ24548503-248D46CA-77AF-46A7-B7B0-A751B4CCBEFEQ24550765-B798D581-14F8-4EE2-A4BD-E45A2479EB35Q24552532-9D410CBC-20DD-4D05-BCB7-4218A7D0C735Q24554258-43B3487A-778A-41F8-95F8-51FE93794D0CQ24554329-F1059707-97C4-4010-8598-36ECD5807102Q24554421-54ACC265-CB1D-498A-A675-9A50748759C5
P2860
Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro
description
1997 nî lūn-bûn
@nan
1997 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro
@ast
Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro
@en
type
label
Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro
@ast
Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro
@en
prefLabel
Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro
@ast
Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro
@en
P2093
P2860
P3181
P356
P1433
P1476
Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro
@en
P2093
Marshall N
Marshall T
Mathews MB
Ramanathan Y
P2860
P304
P3181
P356
10.1101/GAD.11.20.2622
P407
P577
1997-10-15T00:00:00Z